294 related articles for article (PubMed ID: 19151568)
21. Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin-induced sensory neuropathy in gastrointestinal cancers.
Xu XT; Dai ZH; Xu Q; Qiao YQ; Gu Y; Nie F; Zhu MM; Tong JL; Ran ZH
J Dig Dis; 2013 Jun; 14(6):288-98. PubMed ID: 23432969
[TBL] [Abstract][Full Text] [Related]
22. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.
Argyriou AA; Chroni E; Koutras A; Iconomou G; Papapetropoulos S; Polychronopoulos P; Kalofonos HP
J Pain Symptom Manage; 2006 Sep; 32(3):237-44. PubMed ID: 16939848
[TBL] [Abstract][Full Text] [Related]
23. Clinical challenges: chemotherapy-induced peripheral neuropathy.
Paice JA
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
[TBL] [Abstract][Full Text] [Related]
24. Peripheral neuropathy induced by microtubule-stabilizing agents.
Lee JJ; Swain SM
J Clin Oncol; 2006 Apr; 24(10):1633-42. PubMed ID: 16575015
[TBL] [Abstract][Full Text] [Related]
25. Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy: a case series.
Park JW; Jeon JH; Yoon J; Jung TY; Kwon KR; Cho CK; Lee YW; Sagar S; Wong R; Yoo HS
Integr Cancer Ther; 2012 Jun; 11(2):166-71. PubMed ID: 21715371
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer.
Zhao JG; Qiu F; Xiong JP; Zhang L; Xiang XJ; Yu F; Yan J; Zhan ZY; Feng M
Anticancer Drugs; 2009 Apr; 20(4):281-6. PubMed ID: 19247179
[TBL] [Abstract][Full Text] [Related]
27. Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.
Milla P; Airoldi M; Weber G; Drescher A; Jaehde U; Cattel L
Anticancer Drugs; 2009 Jun; 20(5):396-402. PubMed ID: 19287306
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
Wolf S; Barton D; Kottschade L; Grothey A; Loprinzi C
Eur J Cancer; 2008 Jul; 44(11):1507-15. PubMed ID: 18571399
[TBL] [Abstract][Full Text] [Related]
30. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
Kurt S; Can G
Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
[TBL] [Abstract][Full Text] [Related]
31. [Peripheral neuropathies caused by drugs].
Uldry PA; Regli F
Schweiz Rundsch Med Prax; 1989 Jun; 78(23):667-70. PubMed ID: 2546239
[TBL] [Abstract][Full Text] [Related]
32. [Peripheral neuropathy in cancer].
Storstein A; Vedeler C; Johannesen DC
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):194-7. PubMed ID: 11475199
[TBL] [Abstract][Full Text] [Related]
33. Sweet bee venom pharmacopuncture for chemotherapy-induced peripheral neuropathy.
Yoon J; Jeon JH; Lee YW; Cho CK; Kwon KR; Shin JE; Sagar S; Wong R; Yoo HS
J Acupunct Meridian Stud; 2012 Aug; 5(4):156-65. PubMed ID: 22898064
[TBL] [Abstract][Full Text] [Related]
34. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
Nakane M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
[TBL] [Abstract][Full Text] [Related]
35. Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients.
Garg P; Rana F; Gupta R; Buzaianu EM; Guthrie TH
Breast J; 2009; 15(4):404-8. PubMed ID: 19508671
[TBL] [Abstract][Full Text] [Related]
36. Evaluation and management of peripheral neuropathy in diabetic patients with cancer.
Visovsky C; Meyer RR; Roller J; Poppas M
Clin J Oncol Nurs; 2008 Apr; 12(2):243-7. PubMed ID: 18390460
[TBL] [Abstract][Full Text] [Related]
37. Medication and toxin-induced peripheral neuropathy.
Pratt RW; Weimer LH
Semin Neurol; 2005 Jun; 25(2):204-16. PubMed ID: 15937736
[TBL] [Abstract][Full Text] [Related]
38. [Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosya-jinki-gan].
Yamamoto T; Murai T; Ueda M; Katsuura M; Oishi M; Miwa Y; Okamoto Y; Uejima E; Taguchi T; Noguchi S; Kurokawa N
Gan To Kagaku Ryoho; 2009 Jan; 36(1):89-92. PubMed ID: 19151569
[TBL] [Abstract][Full Text] [Related]
39. [Peripheral neuropathies and antiretroviral drugs. Preliminary results].
Thiam A; Diagne M; Ndiaye N; Ngom Gueye NF; Diakhate ND; Sow PS; Ndiaye IP
Dakar Med; 2005; 50(3):176-82. PubMed ID: 17633006
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
Hazama S; Watanabe S; Ohashi M; Yagi M; Suzuki M; Matsuda K; Yamamoto T; Suga Y; Suga T; Nakazawa S; Oka M
Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]